UCB SA - BNP Paribas Fortis
UCB SA - BNP Paribas Fortis
UCB SA - BNP Paribas Fortis
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
The limit placed on employees’ participation in the plan is as follows:<br />
• between 1 per cent. and 10 per cent. of each participant’s compensation;<br />
• US$25,000 per annum per participant; and<br />
• maximum of US$ 5 million total ownership by U.S. employees in all forms of share plans over a<br />
rolling period of 12 months.<br />
As of 31 December 2008, the plan had 544 participants (2007: 621). There are no specific vesting<br />
conditions and the share-based payment expense incurred for this plan is immaterial.<br />
(f) Share savings plan in the UK<br />
The purpose of this plan is to encourage the holding of Ordinary Shares by employees in the UK.<br />
Participants save a certain portion of their salary through payroll deductions and <strong>UCB</strong> matches every<br />
five Ordinary Shares bought by each participant with one free Ordinary Shares. Ordinary Shares are<br />
held in an account in the employee’s name by an independent company that acts as a trustee.<br />
Employee contributions to the plan are limited to the lower of: 10 per cent. of each participant’s<br />
compensation or £1,500 per annum per participant. As of 31 December 2008, the plan had 119<br />
participants (2007: 105) and the share-based payment expense incurred for this plan is immaterial.<br />
(g) Share-based payment expense<br />
The total share-based payment expense incurred for the <strong>UCB</strong> Group equity-based compensation plans<br />
amounted to €14 million in 2008 (2007: €10 million).<br />
For a full description of each of the share option plans, the share appreciation rights plan, the share<br />
award plans, the performance share plans, and the options granted in November 2002 which remain<br />
outstanding, please refer to page 64 of the 2008 Annual Report, which is incorporated by reference in<br />
this Prospectus.<br />
A11250830/2.25/23 Oct 2009 104